Overall Status

Terminated (4)

Active, not recruiting (3)

Not yet recruiting (2)

Completed (1)

Enrolling by invitation (1)

Recruiting (1)

Phase

phase 1 (3)

phase 1/phase 2 (3)

n/a (2)

phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (2)

Juno Therapeutics, a Subsidiary of Celgene (2)

Massachusetts General Hospital (2)

Duke University (1)

Idera Pharmaceuticals, Inc. (1)

Marcela V. Maus, M.D.,Ph.D. (1)

Mustang Bio (1)

Sunesis Pharmaceuticals (1)

University Hospital Southampton NHS Foundation Trust (1)

Collaborator

AbbVie (1)

Bayer (1)

Beth Israel Deaconess Medical Center (1)

Dana-Farber Cancer Institute (1)

Genzyme, a Sanofi Company (1)

Sanofi (1)

University of Southampton (1)

Varian Medical Systems (1)

Study Documents

Intervention Type

drug (6)

biological (2)

radiation (2)

genetic (1)

Funder Type

Other (7)

Industry (5)

Study Type

Interventional (9)

Observational (3)

diffuse large b cell lymphoma

Showing NaN - NaN of 12

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED